Filamentous Bacteriophage in Bio/Nano/Technology, Bacterial Pathogenesis and Ecology

Front Cover
Jasna Rakonjac, Bhabatosh Das, Ratmir Derda
Frontiers Media SA, Feb 16, 2017

 Filamentous phage (genus Inovirus) infect almost invariably Gram-negative bacteria. They are distinguished from all other bacteriophage not only by morphology, but also by the mode of their assembly, a secretion-like process that does not kill the host. “Classic” Escherichia colifilamentous phage Ff (f1, fd and M13) are used in display technology and bio/nano/technology, whereas filamentous phage in general have been put to use by their bacterial hosts for adaptation to environment, pathogenesis, biofilm formation, horizontal gene transfer and modulating genome stability. 


Many filamentous phage have a “symbiotic” life style that is often manifested by inability to form plaques, preventing their identification by standard phage-hunting techniques; while the absence or very low sequence conservation between phage infecting different species often complicates their identification through bioinformatics. Nevertheless, the number of discovered filamentous phage is increasing rapidly, along with realization of their significance. “Temperate” filamentous phage whose genomes are integrated into the bacterial chromosome of pathogenic bacteria often modulate virulence of the host. The Vibrio cholerae phage CTXf genome encodes cholera toxin, whereas many filamentous prophage influence virulence without encoding virulence factors. The nature of their effect on the bacterial pathogenicity and overall physiology is the next frontier in understanding intricate relationship between the filamentous phage and their hosts. 

Phage display has been widely used as a combinatorial technology of choice for discovery of therapeutic antibodies and peptide leads that have been applied in the vaccine design, diagnostics and drug development or targeting over the past thirty years. Virion proteins of filamentous phage are integral membrane proteins prior to assembly; hence they are ideal for display of bacterial surface and secreted proteins. The use of this technology at the scale of microbial community has potential to identify host-interacting proteins of uncultivable or low-represented community members. 

Recent applications of Ff filamentous phage extend into protein evolution, synthetic biology and nanotechnology. In many applications, phage serves as a monodisperse long-aspect nano-scaffold of well-defined shape. Chemical or chenetic modifications of this scaffold are used to introduce the necessary functionalities, such as fluorescent labels, ligands that target specific proteins, or peptides that promote formation of inorganic or organic nanostructures. We anticipate that the future holds development of new strategies for particle assembly, site-specific multi-functional modifications and improvement of existing modification strategies. These improvements will render the production of filamentous-phage-templated materials safe and affordable, allowing their applications outside of the laboratory.
 

Contents

Filamentous Bacteriophage in BioNanoTechnology Bacterial Pathogenesis and Ecology
6
Physiological Properties and Genome Structure of the Hyperthermophilic Filamentous Phage OH3 Which Infects Thermus thermophilus HB8
9
The filamentous phage XacF1 causes loss of virulence in Xanthomonas axonopodis pv citri the causative agent of citrus canker disease
20
Environmental cues and genes involved in establishment of the superinfective Pf4 phage of pseudomonas aeruginosa
31
a filamentous phage acquired by yersinia pestis
39
Mechanistic insights into filamentous phage integration in Vibrio cholerae
44
nontraditional applications of the filamentous bacteriophage as a vaccine carrier therapeutic biologic and bioconjugation scaffold
53
Exploring the Secretomes of Microbes and Microbial Communities Using Filamentous Phage Display
71
Intradomain phage display IDPhD of peptides and protein minidomains censored from canonical pIII phage display
90
Combinatorial synthesis and screening of cancer cellspecific nanomedicines targeted via phage fusion proteins
101
Targeting glioblastoma via intranasal administration of Ff bacteriophages
117
Ffnano short functionalized nanorods derived from Ff f1 fd or M13 filamentous bacteriophage
128
Chemical strategies for the covalent modification of filamentous phage
141
Filamentous Phages As a Model System in Soft Matter Physics
148
Back Cover
155
Copyright

Common terms and phrases

Bibliographic information